266 related articles for article (PubMed ID: 26109723)
1. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
[TBL] [Abstract][Full Text] [Related]
2. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
Liu J; Martin HJ; Liao G; Hayward SD
J Virol; 2007 Oct; 81(19):10451-9. PubMed ID: 17634226
[TBL] [Abstract][Full Text] [Related]
3. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.
Fujimuro M; Hayward SD
J Virol; 2003 Jul; 77(14):8019-30. PubMed ID: 12829841
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation.
Liu J; Martin H; Shamay M; Woodard C; Tang QQ; Hayward SD
J Virol; 2007 May; 81(9):4722-31. PubMed ID: 17314169
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.
Fujimuro M; Liu J; Zhu J; Yokosawa H; Hayward SD
J Virol; 2005 Aug; 79(16):10429-41. PubMed ID: 16051835
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the chromatin binding domain of KSHV LANA.
Woodard C; Shamay M; Liao G; Zhu J; Ng AN; Li R; Newman R; Rho HS; Hu J; Wan J; Qian J; Zhu H; Hayward SD
PLoS Pathog; 2012; 8(10):e1002972. PubMed ID: 23093938
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
Bubman D; Guasparri I; Cesarman E
Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
[TBL] [Abstract][Full Text] [Related]
10. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
[TBL] [Abstract][Full Text] [Related]
11. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
Fujimuro M; Wu FY; ApRhys C; Kajumbula H; Young DB; Hayward GS; Hayward SD
Nat Med; 2003 Mar; 9(3):300-6. PubMed ID: 12592400
[TBL] [Abstract][Full Text] [Related]
12. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
13. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
Cai Q; Murakami M; Si H; Robertson ES
J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
[TBL] [Abstract][Full Text] [Related]
14. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
[TBL] [Abstract][Full Text] [Related]
15. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
17. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.
Qin D; Feng N; Fan W; Ma X; Yan Q; Lv Z; Zeng Y; Zhu J; Lu C
BMC Microbiol; 2011 Oct; 11():240. PubMed ID: 22032493
[TBL] [Abstract][Full Text] [Related]
18. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
